Oral Disposition Index Predicts the Development of Future Diabetes Above and Beyond Fasting and 2-h Glucose Levels
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: We sought to determine whether an oral disposition index (DI(O)) predicts the development of diabetes over a 10-year period. First, we assessed the validity of the DI(O) by demonstrating that a hyperbolic relationship exists between oral indexes of insulin sensitivity and beta-cell function. RESEARCH DESIGN AND METHODS: A total of 613 Japanese-American subjects (322 men and 291 women) underwent a 75-g oral glucose tolerance test (OGTT) at baseline, 5 years, and 10 years. Insulin sensitivity was estimated as 1/fasting insulin or homeostasis model assessment of insulin sensitivity (HOMA-S). Insulin response was estimated as the change in insulin divided by change in glucose from 0 to 30 min (DeltaI(0-30)/DeltaG(0-30)). RESULTS: DeltaI(0-30)/DeltaG(0-30) demonstrated a curvilinear relationship with 1/fasting insulin and HOMA-S with a left and downward shift as glucose tolerance deteriorated. The confidence limits for the slope of the log(e)-transformed estimates included -1 for DeltaI(0-30)/DeltaG(0-30) versus 1/fasting insulin for all glucose tolerance groups, consistent with a hyperbolic relationship. When HOMA-S was used as the insulin sensitivity measure, the confidence limits for the slope included -1 only for subjects with normal glucose tolerance (NGT) or impaired fasting glucose (IFG)/impaired glucose tolerance (IGT) but not diabetes. On the basis of this hyperbolic relationship, the product of DeltaI(0-30)/DeltaG(0-30) and 1/fasting insulin was calculated (DI(O)) and decreased from NGT to IFG/IGT to diabetes (P < 0.001). Among nondiabetic subjects at baseline, baseline DI(O) predicted cumulative diabetes at 10 years (P < 0.001) independent of age, sex, BMI, family history of diabetes, and baseline fasting and 2-h glucose concentrations. CONCLUSIONS: The DI(O) provides a measure of beta-cell function adjusted for insulin sensitivity and is predictive of development of diabetes over 10 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 The computed slopes (——) and 95% CIs for the slopes (– – –) for ln(ΔI0–30/ΔG0–30) versus ln(1/fasting insulin) are plotted for subjects with NGT (slope −0.87 [95% CI −1.13 to −0.61]) (A), IGM (−0.84 [−1.05 to −0.63]) (B), and diabetes (DM) (−0.76 [−1.16 to −0.35]) (C). D: The hyperbolic curves for NGT, IGM, and diabetes, assuming a slope of −1, are plotted for ΔI0–30/ΔG0–30 versus 1/fasting insulin.](https://figures.cochat.ai/paper-figures/d5959647a3dd4b95864a9b906f9e5ab4/oral-disposition-index-predicts-the-development-of-future-diabetes-above-and-figure-1.jpg)
![Figure 2 A: The DIO (ΔI0–30/ΔG0–30 × 1/fasting insulin) decreases from NGT to IGM to diabetes (DM) (median [interquartile range]). B: The logarithmic means for baseline ΔI0–30/ΔG0–30 and 1/fasting insulin values are plotted for subjects with NGT (▪ and □) and IGM (• and ○) as nonprogressors (▪ and •) and progressors (□ and ○) relative to the hyperbolic curves. Progressors had lower β-cell function at baseline. C: The number of subjects who developed diabetes over the 10-year follow-up period by quintiles of baseline DIO. D: ROC curves comparing ability of baseline ΔI0–30/ΔG0–30 (dotted line), 1/fasting insulin (dashed line), and DIO (solid line) to predict cumulative diabetes at 10 years.](https://figures.cochat.ai/paper-figures/739976092a5449f2822cbdd9e3aacbd4/oral-disposition-index-predicts-the-development-of-future-diabetes-above-and-figure-2.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“whereas children and adults with a low disposition index are most likely to progress to type 2 diabetes (19,34–38).”
From Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism (2019) · cites this paper as [38]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784 · cited 1×
“Classification of glucose tolerance Using the 2003 American Diabetes Association criteria (18), subjects were categorized as having normal glucose tolerance (NGT) (fasting plasma glucose [FPG] 5.”
MethodKahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-002-1009-0 · Cited by 2,166 · cited 2×
“Abnormalities in -cell function are present in high-risk individuals long before they develop hyperglycemia (1).”
BackgroundSelf-citationCorrect Homeostasis Model Assessment (HOMA) Evaluation Uses the Computer Program
Levy, J. C., Matthews, D. R., & Hermans, M. P. (1998) · Diabetes Care · doi:10.2337/diacare.21.12.2191 · Cited by 2,013
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Bergman, R. N., Phillips, L. S., & Cobelli, C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110398 · Cited by 1,640 · cited 1×
“sensitivity and insulin responses (2,3),”
Statistical Methods in Medical Research
Armitage, P., Berry, G., & Matthews, J. N. S. (2002) · Wiley eBooks · doi:10.1002/9780470773666 · Cited by 1,630
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405 · cited 4×
“intravenous tests (3) as well as between”
BackgroundInfluentialSelf-citationBuchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339
TCF7L2 Polymorphisms and Progression to Diabetes in the Diabetes Prevention Program
Florez, J. C., Jablonski, K. A., Bayley, N., Pollin, T. I., de Bakker, P. I. W., Shuldiner, A. R., Knowler, W. C., Nathan, D. M., & Altshuler, D. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062418 · Cited by 839
Cited by
Items 201–300 of 569
Brooks-Worrell, B., Hampe, C. S., Hattery, E. G., Palomino, B., Zangeneh, S. Z., Utzschneider, K., Kahn, S. E., Larkin, M. E., Johnson, M. L., Mather, K. J., et al. (2022) · Diabetes · doi:10.2337/db21-0590 · Cited by 33
Self-citationCentofanti, S. A., Heilbronn, L. K., Wittert, G., Dorrian, J., Coates, A. M., Kennaway, D. J., Gupta, C. C., Stepien, J. M., CATCHESIDE, P. G., Yates, C., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06279-1 · Cited by 27
Hu, Y., Liu, J., Li, H., Zhu, H. J., Liu, L., Yuan, Y., Chen, J., Wang, Y., Hu, X., & Xu, Y. (2018) · PeerJ · doi:10.7717/peerj.4515 · Cited by 24
“…the effect of insulin sensitivity on these indexes, several researchers developed 125 the early-phase insulin disposition index (DI30) and the total insulin disposition index (DI120) to 126 assess insulin secretion with respect to insulin sensitivity (Utzschneider et al. 2009; Ram et al. 127 2015).”
Cheng, F., Zhao, L., Wu, Y., Huang, T., Yang, G., Zhang, Z., Wu, Y., Jia, F., Wu, J., Chen, C., et al. (2015) · Clinical Endocrinology · doi:10.1111/cen.12950 · Cited by 27
Anjana, R. M., Ranjani, H., Ranjit Unnikrishnan, I., Weber, M. B., Mohan, V., & Narayan, K. M. V. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.09.053 · Cited by 28
Interactions between genetic background, insulin resistance and β‐cell function
Kahn, S. E., Suvag, S., Wright, L. A.-C., & Utzschneider, K. M. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01650.x · Cited by 28
Self-citationInsulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone
Manu, P., Correll, C. U., Wampers, M., van Winkel, R., Yu, W., Shiffeldrim, D., Kane, J. M., & Binder, M. D. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.11.016 · Cited by 25
Sullivan, S. D., Jablonski, K. A., Florez, J. C., Dabelea, D., Franks, P. W., Dagogo-Jack, S. E., Kim, C., Knowler, W. C., Christophi, C. A., & Ratner, R. E. (2013) · Diabetes Care · doi:10.2337/dc13-0700 · Cited by 26
Impact of Major Depressive Disorder on Prediabetes by Impairing Insulin Sensitivity
Shelton, R. C., & Li, L. (2016) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000664 · Cited by 23
Ha, K. H., Park, C., Jeong, I., Kim, H. J., Kim, S. Y., Kim, W. J., Yoon, J. S., Kim, D. J., Kim, S., & Kim, S. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.42.2.137 · Cited by 27
Bourne, J. E., Little, J. P., Beauchamp, M. R., Barry, J., Singer, J., & Jung, M. E. (2019) · JMIR Research Protocols · doi:10.2196/11226 · Cited by 24
“…calculate homeostasis model assessment of insulin resistance using the Web-based Homeostasis Model Assessment-2 calculator, a validated method that is highly correlated ( r =.88) with the hyperinsulinemic-euglycemic clamp [66] and is sensitive to change following exercise interventions [65,67,68].”
Chin, S. O., Hwang, Y., Cho, I.-J., Jeong, I., Ahn, K. J., & Chung, H. Y. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3425 · Cited by 24
Colleluori, G., Napoli, N., Phadnis, U., Armamento-Villareal, R., & Villareal, D. T. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4807046 · Cited by 22
“A low DI is an early marker of inadequate β-cell compensation which predicts future diabetes [25].”
BackgroundZhang, Y., Chen, H.-B., Lu, H., Shen, Y., Chen, R., Fang, P., Du, X., Bao, Y., Wang, C., & Jia, W. (2015) · Diabetic Medicine · doi:10.1111/dme.13013 · Cited by 22
Circulating Irisin Levels as a Marker of Osteosarcopenic-Obesity in Cushing’s Disease
Guarnotta, V., Prinzi, A., Pitrone, M., Pizzolanti, G., & Giordano, C. S. D. S. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s249090 · Cited by 24
Vitamin D Deficiency in Cushing’s Disease: Before and After Its Supplementation
Guarnotta, V., Gaudio, F. D., & Giordano, C. S. D. S. (2022) · Nutrients · doi:10.3390/nu14050973 · Cited by 25
“As markers of insulin sensitivity, we calculated the homeostatic model of insulin resistance (HOMA2-IR) [38], and in 32 patients with CD and in 40 controls who had no previous diagnosis of diabetes, we also evaluated the Matsuda index of insulin sensitivity (ISI-Matsuda) [39], the oral disposition index (DIo) [40] and…”
MethodWolf, P. S., Dormoy, A., Maione, L., Salenave, S., Young, J., Kamenický, P., & Chanson, P. (2022) · Endocrine Connections · doi:10.1530/ec-22-0296 · Cited by 22
Murro, E. D., Giuseppe, G. D., Soldovieri, L., Moffa, S., Improta, I., Capece, U., Nista, E. C., Cinti, F., Ciccarelli, G., Brunetti, M., et al. (2023) · Nutrients · doi:10.3390/nu15194202 · Cited by 27
Chatterjee, R., Slentz, C. A., Davenport, C. A., Johnson, J. L., Lin, P., Muehlbauer, M. J., D’Alessio, D. A., Svetkey, L. P., & Edelman, D. E. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.161570 · Cited by 25
François, M. E., Gilbertson, N. M., Eichner, N. Z. M., Heiston, E. M., Fabris, C., Breton, M. D., Mehaffey, J. H., Hassinger, T. E., Hallowell, P. T., & Malin, S. K. (2018) · Nutrients · doi:10.3390/nu10060717 · Cited by 23
“The oral disposition index (DI) is a measure of pancreatic insulin secretion [6,7] and is a stronger predictor of future T2D risk than insulin sensitivity alone [8].”
BackgroundKim, J. Y., Tfayli, H. M., Bacha, F. F., Lee, S., Michaliszyn, S. F., Yousuf, S., Gebara, N. Y., & Arslanian, S. A. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12940 · Cited by 22
“The diminished DI or the β-cell function relative to insulin sensitivity in the Late-peak group is considered the most powerful metabolic predictor for the future development of type 2 diabetes.(34,35) Our OGTT-based data in the total cohort were consistent with our clamp-based data showing lower HOMA-IS, lower insuli…”
ResultLi, L., Garvey, W. T., & Gower, B. A. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00151 · Cited by 21
Hoffman, R. P., Copenhaver, M. M., Zhou, D., & Yu, C. Y. (2019) · Pediatric Diabetes · doi:10.1111/pedi.12896 · Cited by 22
“by multiplying both these values (DI = IS × IGI).(26) Disposition index is an important predictor of future type 2 diabetes.”
BackgroundMethodKhatiwada, S., Agarwal, S., Kandasamy, D., Jyotsna, V. P., Kumar, R., Bansal, V. K., Pandey, R. M., Gupta, N., & Tandon, N. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.10.030 · Cited by 21
Revisiting the Pattern of Loss of β-Cell Function in Preclinical Type 1 Diabetes
Martino, M., Galderisi, A., Evans‐Molina, C., & Dayan, C. M. (2024) · Diabetes · doi:10.2337/db24-0163 · Cited by 21
the EMPHASIS study group, Chandak, G. R., Silver, M. J., Saffari, A., Lillycrop, K. A., Shrestha, S., Sahariah, S. A., Gravio, C. D., Goldberg, G. R., Tomar, A. S., et al. (2017) · BMC Nutrition · doi:10.1186/s40795-017-0200-0 · Cited by 25
“uk/homacalculator/ d Disposition index: an estimate of insulin secretion taking into account insulin resistance, to be calculated as insulinogenic index/HOMA-IR [52] e High blood pressure defined as >99th percentile according to an international reference: https://www.”
MethodCirculating pro-neurotensin levels predict bodyweight gain and metabolic alterations in children
Barchetta, I., Bertoccini, L., Sentinelli, F., Bailetti, D., Marini, G., Cimini, F. A., Ceccarelli, V., Struck, J., Schulte, J., Loche, S., et al. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.11.025 · Cited by 24
Rasouli, N., Younes, N., Utzschneider, K. M., Inzucchi, S. E., Balasubramanyam, A., Cherrington, A., Ismail‐Beigi, F., Cohen, R. M., Olson, D. E., DeFronzo, R. A., et al. (2020) · Diabetes Care · doi:10.2337/dc20-1787 · Cited by 23
Self-citationBreuer, T. G. K., Menge, B. A., Banasch, M., Uhl, W., Tannapfel, A., Schmidt, W. E., Nauck, M. A., & Meier, J. J. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0330 · Cited by 20
Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism
Grewal, S., Fosam, A., Chalk, L., Deven, A., Suzuki, M., Correa, R. R., Blau, J. E., Demidowich, A. P., Stratakis, C. A., & Muniyappa, R. (2021) · Endocrine · doi:10.1007/s12020-020-02576-y · Cited by 20
Billings, L. K., Jablonski, K. A., Warner, A. S., Cheng, Y.-C., McAteer, J. B., Tipton, L., Shuldiner, A. R., Ehrmann, D. A., Manning, A. K., Dabelea, D., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-3429 · Cited by 20
Self-citationRetnakaran, R. R., Pu, J., Shen, J., Hanley, A. J., & Zinman, B. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00163-9 · Cited by 20
Peters, B., Schwarz, J., Schuppelius, B., Ottawa, A., Koppold, D. A., Weber, D., Steckhan, N., Mai, K., Grune, T., Pfeiffer, A. F. H., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adv6787 · Cited by 25
Lytrivi, M., Cauduro, C. G. D. S., Kibanda, J., Kristanto, P., Paesmans, M., & Cnop, M. (2023) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.07.018 · Cited by 21
Qvigstad, E., Voldner, N., Godang, K., Henriksen, T., & Bollerslev, J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-09-0416 · Cited by 20
The kidney’s role in systemic metabolism—still much to learn
de Boer, I. H., & Utzschneider, K. M. (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfx027 · Cited by 20
Self-citationKim, Y. A., Ku, E. J., Khang, A. R., Hong, E. S., Kim, K. M., Moon, J. H., Choi, S. H., Park, K. S., Jang, H. C., & Lim, S. K. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.08.014 · Cited by 24
Kotzaeridi, G., Blätter, J., Eppel, D., Rosicky, I., Falcone, V., Adamczyk, G., Linder, T., Yerlikaya‐Schatten, G., Weißhaupt, K., Henrich, W., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204794 · Cited by 22
“, the capability of the pancreatic β-cells to adapt for the amount of insulin resistance) from fasting parameters [13].”
BackgroundJagannathan, R., Snehalatha, C., Selvam, S., Nanditha, A., Shetty, A. S., Godsland, I. F., Johnston, D. G., & Ramachandran, A. (2015) · Acta Diabetologica · doi:10.1007/s00592-015-0718-z · Cited by 20
“An observational study of 10 years in Japanese American individuals showed a strong association of oral disposition index (DI0–30/DG0–30 * 1/fasting insulin) with incident diabetes [22].”
BackgroundAye, M., Kilpatrick, E. S., Afolabi, P. R., Wootton, S. A., Rigby, A. S., Coady, A., Sandeman, D. D., & Atkin, S. L. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12255 · Cited by 20
Prodam, F., Savastio, S., Genoni, G., Babu, D., Giordano, M., Ricotti, R., Aimaretti, G., Bona, G., & Bellone, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087157 · Cited by 21
“Moreover, we chose the OGTT-derived indices of insulin sensitivity and secretion because they correlate well with clamp measures in children [44,45], are easily calculated in epidemiological or intervention studies, and DI calculated by the OGTT has been demonstrated to predict diabetes development in adults [24].”
MethodVinciguerra, F., Tumminia, A., Baratta, R., Ferro, A., Alaimo, S., Hagnäs, M. P., Graziano, M., Vigneri, R., & Frittitta, L. (2020) · Life · doi:10.3390/life10080127 · Cited by 26
Tommerdahl, K. L., Brinton, J. T., Vigers, T., Cree‐Green, M., Zeitler, P. S., Nadeau, K. J., & Chan, C. L. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2020.08.020 · Cited by 19
“Class IVV 2 (18) 1 (2) 1 (13) 2 (5) 1 (8) 2 (5) 1 (25) 2 (4)”
Indices of Insulin Secretion during a Liquid Mixed-Meal Test in Obese Youth with Diabetes
Bacha, F. F., Gungor, N., Lee, S., Heras, J. D. L., & Arslanian, S. A. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.11.037 · Cited by 20
Insulin Resistance in Pregnancy: Implications for Mother and Offspring
Hernandez, T. L., Friedman, J. E., & Barbour, L. A. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_5 · Cited by 25
DeFronzo, R. A., & Abdul‐Ghani, M. A. (2009) · Diabetes Care · doi:10.2337/dc09-0537 · Cited by 19
One-Hour Plasma Glucose Predicts the Progression From Normal Glucose Tolerance to Prediabetes
Abdul‐Ghani, M. A., Abu‐Farha, M., Abdul‐Ghani, T., Chavez-Velazquez, A., Merovci, A., DeFronzo, R. A., Al-Ajmi, F. A., Stern, M. P., & Al‐Mulla, F. (2025) · Diabetes Care · doi:10.2337/dc24-2832 · Cited by 18
Hanson, A. J., Banks, W. A., Hernandez Saucedo, H., & Craft, S. (2016) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000444079 · Cited by 17
Lipoatrophic diabetes in familial partial lipodystrophy type 2: From insulin resistance to diabetes
Treiber, G., Guilleux, A., Huynh, K., Bonfanti, O., Flaus–Furmaniuk, A., Couret, D., Mellet, N. A., Bernard, C., Moullec, N. L., Doray, B., et al. (2022) · Diabetes & Metabolism · doi:10.1016/j.diabet.2022.101409 · Cited by 18
Prior undernutrition and insulin production several years later in Tanzanian adults
Filteau, S., PrayGod, G., Rehman, A. M., Peck, R. N., Jeremiah, K., Krogh‐Madsen, R., & Faurholt‐Jepsen, D. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa438 · Cited by 24
“We are not certain why we found a higher proportion of participants with negative or undefined (due to no change in glucose) values of EIR compared with proportions found by others (23, 42).”
MethodResultBantle, A., Lau, K. J., Wang, Q., Malaeb, S., Harindhanavudhi, T., Manoogian, E. N. C., Panda, S., Mashek, D. G., & Chow, L. S. (2022) · Obesity · doi:10.1002/oby.23620 · Cited by 21
“It has been shown to be predictive of future T2DM risk [35].”
BackgroundTjandrawinata, R. R., Manaf, A., Malinda, D., & Susanto, L. W. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s97568 · Cited by 23
Marzuillo, P., Sessa, A. D., Umano, G. R., Nunziata, L., Cirillo, G., Perrone, L., del Giudice, E. M., & Grandone, A. (2016) · Pediatric Diabetes · doi:10.1111/pedi.12417 · Cited by 18
Aitken, M. L., Szkudlinska, M. A., Boyko, E. J., Ng, D. M., Utzschneider, K. M., & Kahn, S. E. (2020) · Diabetologia · doi:10.1007/s00125-020-05096-6 · Cited by 18
“As beta cell function is represented by insulin responses adjusted for the prevailing insulin sensitivity, using the known hyperbolic relationship between 1/fasting insulin (as a surrogate of insulin sensitivity) and the early insulin response over 30 min in the OGTT [12], we calculated beta cell function as DIo.”
MethodSelf-citationZhang, D., Zhong, X., Cheng, C., Su, Z., Xue, Y., Liu, Y., Zhang, Y., Feng, M., Xu, Z., Zhao, T., et al. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.2c05469 · Cited by 20
Trinh, B., Rasmussen, S. J., Brøgger-Jensen, M. E., Engelhard, C. A., Lund, A., Tavanez, A. R., Vassilieva, A., Janum, S., Iepsen, U. W., Kiens, B., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102042 · Cited by 19
Wu, J., Wu, Y., Zhang, X., Li, S., Lu, D., Li, S., Yang, G., & Liu, D. (2013) · Clinical Endocrinology · doi:10.1111/cen.12192 · Cited by 17
Watanabe, D., Kuranuki, S., Sunto, A., Matsumoto, N., & Nakamura, T. (2018) · Nutrients · doi:10.3390/nu10121834 · Cited by 17
“The oral disposition index (DI), which is a composite measure of beta-cell function, was calculated as ∆I0-30/∆G0-30 × 1/FSI [μg/mL] [24].”
Sanctis, V. D., Soliman, A. T., Tzoulis, P., Daar, S., Karimi, M., Yassin, M. A., Pozzobon, G. C., & KATTAMIS, C. A. (2022) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v92i6.12366 · Cited by 24
Assessment of β-cell function in human patients
Choi, C. S., Kim, M. Y., Han, K., & Lee, M. (2012) · Islets · doi:10.4161/isl.19270 · Cited by 22
Alzahrani, S., Nelson, J., Moss, S. F., Paulus, J. K., Knowler, W. C., & Pittas, A. G. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.05.015 · Cited by 18
Insulin Secretion and Risk for Future Diabetes in Subjects with a Nonpositive Insulinogenic Index
Aono, D., Oka, R., Kometani, M., Takeda, Y., Karashima, S., Yoshimura, K., Takeda, Y., & Yoneda, T. (2018) · Journal of Diabetes Research · doi:10.1155/2018/5107589 · Cited by 18
Arpón, A., Santos, J. L., Milagro, F. I., Cataldo, L. R., Bravo, C., Riezu‐Boj, J. I., & Martínez, J. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122928 · Cited by 18
“Additionally, it has been reported that both DI and the oral disposition index (ODI) based on OGTT are relevant predictors of future T2D development [12].”
BackgroundMechanisms for increased risk of diabetes in chronic liver diseases
Svegliati‐Baroni, G., Gaggini, M., Carli, F., Barbieri, C., Cucco, M., Younes, R., Rosso, C., Bugianesi, E., & Gastaldelli, A. (2020) · Liver International · doi:10.1111/liv.14556 · Cited by 17
Beta Cell Function as a Baseline Predictor of Weight Loss After Bariatric Surgery
Borges‐Canha, M., Neves, J. S., Mendonça, F. M., Silva, M. M., Costa, C. F., Cabral, P. M., Guerreiro, V. A., Lourenço, R., Meira, P., Salazar, D. A., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.714173 · Cited by 20
Colleluori, G., Viola, V., Bathina, S., Armamento‐Villareal, R., Qualls, C., Giordano, A., & Villareal, D. T. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.05.016 · Cited by 15
Complement C3 Is the Strongest Predictor of Whole-Body Insulin Sensitivity in Psoriatic Arthritis
Ursini, F., D’Angelo, S., Russo, E., Nicolosi, K., Gallucci, A., Chiaravalloti, A., Bruno, C., Naty, S., Sarro, G. D., Olivieri, I., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163464 · Cited by 16
A proteomic signature that reflects pancreatic beta-cell function
Curran, A. M., Scott‐Boyer, M., Kaput, J., Ryan, M. F., Drummond, E. M., Gibney, E. R., Gibney, M. J., Roche, H. M., & Brennan, L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202727 · Cited by 17
Fan, K., Wu, H., Wei, J., Chuang, L., Hsu, C., Yen, I., Lin, C., Lin, M., Shih, S., Wang, S., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa103 · Cited by 16
Wolf, R. M., Jaffe, A. E., Rodriguez, S., Lei, X., Sarver, D. C., Straub, A. T., Wong, G. W., & Magge, S. N. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00626.2020 · Cited by 17
Li, C., Yang, H., Tong, G., Shen, S., Feng, W., Bi, Y., & Zhu, D. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0563-5 · Cited by 16
Yoshimura, K., Hirano, S., Takata, H., Funakoshi, S., Ohmi, S., Amano, E., Nishi, Y., Inoue, M., Fukuda, Y., Hayashi, H., et al. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12622 · Cited by 17
Recent Glycemia Is a Major Determinant of β-Cell Function in Type 2 Diabetes Mellitus
Kim, J. Y., Lee, J. Y., Kim, S. G., & Kim, N. H. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2023.0359 · Cited by 20
Shi, Y., Sun, M., Wang, Z., Hsu, H.-T., Shen, M., Yang, T., & Fu, Q. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108080 · Cited by 16
Martínez‐Sánchez, F. D., Vargas-Abonce, V. P., Rocha-Haro, A., Flores-Cárdenas, R., Fernández-Barrio, M., Guerrero-Castillo, A. P., Meza-Arana, C. E., Gulías-Herrero, A., & Gómez-Sámano, M. Á. (2021) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2021.100013 · Cited by 17
Stanislawski, M. A., LITKOWSKI, E. M., Raghavan, S., Harrall, K. K., Shaw, J. R., Glueck, D. H., Lange, E. M., Dabelea, D., & Lange, L. A. (2021) · Diabetes Care · doi:10.2337/dc21-0464 · Cited by 17
Cubeddu, L. X., & Hoffmann, I. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2010.0010 · Cited by 16
Ohmi, S., Ono, M., Takata, H., Hirano, S., Funakoshi, S., Nishi, Y., Yoshimura, K., Amano, E., Terada, Y., Saibara, T., et al. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0264-7 · Cited by 17
“Oral disposition index (DIO) was calculated using the following formula [14]: IGI/I0 (pmol/L).”
MethodResultElder, D. A., Hornung, L. N., Khoury, J. C., & D’Alessio, D. A. (2017) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2017.06.007 · Cited by 15
Sanctis, V. D., Soliman, A. T., Tzoulis, P., Daar, S., Maio, S. D., Fiscina, B., & KATTAMIS, C. A. (2021) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2021.051 · Cited by 15
Brain substrate metabolism and ß‐cell function in humans: A positron emission tomography study
Rebelos, E., Mari, A., Bucci, M., Honka, M., Hannukainen, J. C., Virtanen, K. A., Hirvonen, J., Nummenmaa, L., Heni, M., Iozzo, P., et al. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.136 · Cited by 14
Swauger, S. E., Hornung, L. N., Elder, D. A., Balamurugan, A. N., Vitale, D. S., Lin, T. K., Nathan, J. D., & Abu‐El‐Haija, M. A. (2022) · Diabetes Care · doi:10.2337/dc21-1222 · Cited by 14
Kufe, C. N., Micklesfield, L. K., Masemola, M., Chikowore, T., Kengne, A. P., Karpe, F., Norris, S. A., Crowther, N. J., Olsson, T., & Goedecke, J. H. (2022) · European Journal of Endocrinology · doi:10.1530/eje-21-0527 · Cited by 14
“Indeed, a lower beta-cell function, estimated using the oDI, has been shown to predict the development of T2D over a 10-year period in a Japanese American cohort (26).”
Komada, H., Sakaguchi, K., Takeda, K., Hirota, Y., Hashimoto, N., Okuno, Y., Seino, S., & Ogawa, W. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00099.x · Cited by 14
Lee, J.-E., Oh, T. J., Moon, J. H., Park, K. S., Jang, H. C., & Choi, S. H. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00043 · Cited by 14
“The disposition index, which reflects β-cell function, was calculated as [30-min insulin concentration (μU/ml) – fasting insulin concentration (μU/ml)]/[PP30 (mg/dl) – FPG (mg/dl)]/HOMAIR (27, 28).”
MethodLong‐term maternal cardiometabolic outcomes 22 years after gestational diabetes mellitus
Tutino, G., Tam, C. H., Ozaki, R., Yuen, L. Y., So, W. Y., Chan, M. H. M., Ko, G. T. C., Yang, X., Chan, J. C. N., Tam, W. H., et al. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13209 · Cited by 14
Chen, P.-H., Tsai, Y.-T., Wang, J., Lin, S.-D., Lee, W.-J., Su, S., Lee, I., Tu, S., Tseng, Y., Sheu, W. H., et al. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-68 · Cited by 14
“005; § total area under curve of insulin within 120 minutes divided by total a DI, disposition index; HOMA-β, homeostasis model assessment β-cell function; HOM Incremental AUC, incremental area under curve during liquid mixed meal tolerance glucose tolerance to diabetes mellitus, and can be used to predict the develop…”
MethodCubeddu, L. X., & Hoffmann, I. (2012) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0040 · Cited by 14
Yamauchi, K., Sato, Y., Nakasone, Y., & Aizawa, T. (2015) · Diabetologia · doi:10.1007/s00125-015-3612-x · Cited by 14
“HOMA-β% with the degree of insulin resistance being taken into consideration [2].”
BackgroundThe Role of Wnt3a/β-Catenin/TCF7L2 Pathway in Diabetes and Cardiorenal Complications
Adeerjiang, Y., Sidike, A., Gan, X.-X., Li, Q., & Jiang, S. (2024) · Cardiorenal Medicine · doi:10.1159/000543145 · Cited by 17
Complete loss of SLC30A8 in humans improves glucose metabolism and beta cell function
Lamarche, L. B., Koch, C., Khalid, S., Khan, M. Z., Zessis, R., Clement, M. E., Denning, D. P., Goldfine, A. B., Splawski, I., Abbasi, A., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06530-3 · Cited by 16
“From collected OGTT data, Corrected Insulin Response (CIR30), Matsuda Insulin Sensitivity Index, and oral Disposition Index (DI)[42, 43] were calculated as measures of insulin sensitivity and β -cell function in non-diabetic LoF hetero-and homozygotes (Figure 4B).”
Espinoza, C., Fuenzalida, B., & Leiva, A. (2021) · Current Vascular Pharmacology · doi:10.2174/1570161119666210423085407 · Cited by 15
Arreola, E. V., Hanson, R. L., Bogardus, C., & Knowler, W. C. (2021) · Diabetes · doi:10.2337/db21-0416 · Cited by 15
Kong, X., Xing, X., Hong, J., Zhang, X., & Yang, W. (2016) · Clinical Genetics · doi:10.1111/cge.12817 · Cited by 15
Santos, J. L., Cataldo, L. R., Cortés-Rivera, C., Bravo, C., Díaz-Casanova, L., Martínez, J. A., Milagro, F. I., & Galgani, J. E. (2019) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-019-00672-w · Cited by 13
Chen, G., Liu, C., Chen, F., Yao, J. Y., Jiang, Q., Chen, N., Huang, H., Liang, J., Li, L., & Li, L. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02653.x · Cited by 14
Kidney Function, β-Cell Function and Glucose Tolerance in Older Men
Jia, T., Risérus, U., Xu, H., Lindholm, B., Ärnlöv, J., Sjögren, P., Cederholm, T., Larsson, T. E., Ikizler, T. A., & Carrero, J. J. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3313 · Cited by 13
Sheanon, N., Elder, D., Khoury, J., Casnellie, L., Gutmark-Little, I., Cernich, J., & Backeljauw, P. F. (2021) · Hormone Research in Paediatrics · doi:10.1159/000520233 · Cited by 12
Exocrine and endocrine functions and pancreatic volume in patients with pancreatic trauma
Colney, L., Tandon, N., Garg, P. K., Gupta, N., Sagar, S., Gupta, A., Kumar, A., & Kumar, S. (2021) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-021-01638-8 · Cited by 12
Rezaie, P., Bitarafan, V., Rose, B. D., Lange, K. M., Mohammadpour, Z., Rehfeld, J. F., Horowitz, M., & Feinle‐Bisset, C. (2023) · Nutrients · doi:10.3390/nu15163584 · Cited by 13
“The oral disposition index was then calculated as ∆AUCinsulin-1 to 30/∆AUCglucose-1 to 30 × 1/fasting insulin [33] and analysed using repeated measures one-way ANOVA with treatment (QHCl-600, QHCl-300 and control) as a factor.”
Method
Metadata
- Authors
- Utzschneider, K. M., Prigeon, R. L., Faulenbach, M. V., Tong, J., Carr, D. B., Boyko, E. J., Leonetti, D. L., McNeely, M. J., Fujimoto, W. Y., & Kahn, S. E.
- Affiliations
- University of Washington (US)
- University of Maryland, Baltimore (US)
- VA Puget Sound Health Care System (US)
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-02-01
- Volume
- 32
- Issue
- 2
- Pages
- 335-341
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2628704
- OpenAlex
- W2121328463
- Cited by
- 572
- References
- 27
- Citations by year
- 2026: 24 · 2025: 30 · 2024: 39 · 2023: 41 · 2022: 40 · 2021: 44 · 2020: 41 · 2019: 27 · 2018: 32 · 2017: 32 · 2016: 42 · 2015: 26 · 2014: 35 · 2013: 29 · 2012: 35
- FWCI
- 13.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (P30 DK, HL‐49293, DK-31170)
- National Heart, Lung, and Blood Institute (R01HL049293)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-35816, P30-DK 17047, K24DK002654, DK 02654, R01DK031170, P30DK035816, P30DK017047)
- National Center for Research Resources (RR00037, M01RR000037)
- NIH Clinical Center (RR-00037)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R24HD042828)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- oral disposition index, diabetes prediction, beta-cell function, insulin sensitivity, hyperbolic relationship, oral glucose tolerance test, impaired fasting glucose, impaired glucose tolerance, HOMA-S, fasting insulin
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Fasting, Feedback, Follow-Up Studies, Glucose Tolerance Test, Humans, Hyperglycemia, Insulin, Insulin Resistance, Predictive Value of Tests, Regression Analysis, Time Factors, Reproducibility of Results, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.